NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) recently announced a pivotal shift in its board with the appointment of Luba ...

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

Despite its government spending more than any other on health care both per capita and as a percentage of GDP, spending over $4.5 trillion in 2022, the United States has the lowest life expectancy at ...

The 2024 Pharmacy Benefit Manager Customer Satisfaction Report published by Pharmaceutical Strategies Group ("PSG") disclosed ...

New drug discovery is extremely inefficient. Estimates of the average R&D cost per new drug are less than $1 billion to more ...

NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) recently concluded its 2024 Special Meeting of Stockholders with significant ...

Pharmaceutical companies must prioritize efforts to reach patients in underserved parts of the world with medicines such as insulin for diabetics and, crucially, measure the effectiveness of these ...

An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.

The pharma industry has invested greatly in IT systems and optimized data and content management. Medical device companies can learn from pharma's experience — and it will ease the regulatory burden.

We recently compiled a list of the 10 Best Japanese Stocks To Buy Now. In this article, we are going to take a look at where ...

The Indian pharmaceutical industry is concerned over the talent gap the sector is facing, particularly in areas like data science, digital marketing, and innovative R&D. The industry is undergoing ...